Efficacy and Safety of Canakinumab Vs Triamcinolone Acetonide in Patients with Gouty Arthritis Unable to Use Nonsteroidal Anti-Inflammatory Drugs and Colchicine, and On Stable Urate Lowering Therapy (ULT) or Unable to Use ULT

被引：0
|
作者：
Bardin, T. [1 ]
So, A. [2 ]
Alten, R. [3 ]
Bloch, M. [4 ]
John, M. R. [5 ]
Krammer, G. [5 ]
Nebesky, J. M. [5 ]
Tao, A. [6 ]
Schlesinger, N. [7 ]
机构：
[1] Hop Lariboisiere, Serv Rhumatol, F-75475 Paris, France
[2] Univ Lausanne, CHU Vaudois, Lausanne, Switzerland
[3] Charite, D-13353 Berlin, Germany
[4] Holdsworth House Med Practice, Sydney, NSW, Australia
[5] Novartis Pharma AG, Basel, Switzerland
[6] Novartis Pharmaceut, E Hanover, NJ USA
[7] UMDNJ Robert Wood Johnson Med Sch, New Brunswick, NJ USA
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1911
引用
收藏
页码：S811 / S812
页数：2
相关论文
共 7 条
  • [1] EFFECT OF CANAKINUMAB VS TRIAMCINOLONE ACETONIDE FOR TREATMENT OF GOUTY ARTHRITIS IN PATIENTS WHO ARE UNABLE TO USE NSAIDS AND COLCHICINE OR WITH SEVERE GOUTY ARTHRITIS
    Schlesinger, N.
    Alten, R.
    Bardin, T.
    Bloch, M.
    Shpilsky, A.
    Krammer, G.
    Kiechle, T.
    So, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 439 - 439
  • [2] LONG-TERM SAFETY AND EFFICACY OF CANAKINUMAB VS TRIAMCINOLONE ACETONIDE IN PATIENTS WITH FREQUENT ACUTE GOUTY ARTHRITIS ATTACKS WHO ARE CONTRAINDICATED, INTOLERANT OR UNRESPONSIVE TO NSAIDS AND/OR COLCHICINE
    Alten, R.
    Schlesinger, N.
    So, A.
    Schumacher, H. R.
    Bloch, M. T.
    Machein, U.
    Richard, D.
    Lheritier, K.
    Bardin, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 785 - 785
  • [3] A 3-Year Follow-up Study of Canakinumab in Frequently Flaring Gouty Arthritis Patients, Contraindicated, Intolerant, or Unresponsive to Nonsteroidal Anti-Inflammatory Drugs and/or Colchicine
    Schlesinger, Naomi
    Bardin, Thomas
    Bloch, Mark
    Lheritier, Karine
    Machein, Uwe
    Junge, Guido
    So, Alexander
    Alten, Rieke
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [4] COMPARISON OF EFFICACY AND SAFETY OF DIFFERENT ANTI-INFLAMMATORY DRUGS AT INITIATION OF URATE-LOWERING THERAPY IN PATIENTS WITH GOUT (PRELIMINARY DATA)
    Chikina, M.
    Eliseev, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1757 - 1758
  • [5] Canakinumab in Frequently Flaring Gouty Arthritis Patients, Contraindicated, Intolerant or Unresponsive to non-Steriodal Anti-Inflammatory drugs and/or Colchicine: Safety and Efficacy Results from Long Term Follow-up.
    Schlesinger, Naomi
    Alten, Rieke
    Bardin, Thomas
    Schumacher, H. Ralph, Jr.
    Bloch, Mark
    Lheritier, Karine
    Richard, Dominik
    Stancati, Andrea
    So, Alexander
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S66 - S67
  • [6] SAFETY AND EFFICACY OF CANAKINUMAB IN FREQUENTLY FLARING GOUTY ARTHRITIS PATIENTS WHO ARE CONTRAINDICATED, INTOLERANT OR UNRESPONSIVE TO NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND/OR COLCHICINE: RESULTS FROM 3 YEARS FOLLOW-UP
    Alten, R.
    Bardin, T.
    Bloch, M.
    Lheritier, K.
    Machein, U.
    Junge, G.
    So, A.
    Schlesinger, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 544 - 544
  • [7] Efficacy and Safety of Duloxetine in Patients with Chronic Low Back Pain Who Used versus Did Not Use Concomitant Nonsteroidal Anti-Inflammatory Drugs or Acetaminophen: A Post Hoc Pooled Analysis of 2 Randomized, Placebo-Controlled Trials
    Skljarevski, Vladimir
    Liu, Peng
    Zhang, Shuyu
    Ahl, Jonna
    Martinez, James M.
    PAIN RESEARCH AND TREATMENT, 2012, 2012
1